What Is an MDL? The Court Structure Behind Every Big Lawsuit You've Heard Of
If you've read anything about the big product-liability fights, the firefighting foam, the talc cases, Roundup, the hair-relaxer litigation, you've run into the same three letters over and over: MDL. It gets used as if everyone knows what it means, and most people don't, exactly. They assume it's a class action, or a single giant lawsuit, or some special kind of case. It's none of those. Multidistrict litigation is a piece of court machinery, a way of organizing thousands of separate lawsuits so they can move efficiently through one courtroom, and understanding it demystifies basically every mass tort you'll ever read about.
So here's what an MDL actually is, how cases end up in one, what happens inside it, and the crucial thing it is not.
The problem MDLs were built to solve
Picture what happens when a product allegedly harms a lot of people. A defective drug, a contaminated chemical, a device that fails. Thousands of people, scattered across the country, each file their own lawsuit against the same manufacturer. Without some kind of coordination, you'd have hundreds of judges in dozens of states all separately deciding the same questions, was this product defective, what does the science say, what did the company know, with the same witnesses flying around to repeat the same testimony, and the same documents fought over again and again. It would be chaos, wildly inefficient, and it would produce a patchwork of contradictory rulings.
Multidistrict litigation is the fix. It's a federal procedure, set out in a statute, that lets all those similar federal lawsuits get gathered in front of a single judge for the shared, pretrial part of the process. One judge, handling the common questions once, for all the cases at the same time. That's the whole idea. Efficiency through consolidation.
How cases get into an MDL
The gatekeeper is a body called the Judicial Panel on Multidistrict Litigation, the JPML, a group of federal judges whose job is to decide when scattered lawsuits should be consolidated and where they should go. When a bunch of similar cases start piling up in different federal courts, someone, often the plaintiffs' lawyers or the defendant, petitions the Panel to centralize them.
The Panel weighs whether the cases share enough common questions of fact to justify pooling them, and if so, it picks a single federal district court and a single judge, the transferee court and transferee judge, to handle them all. The Panel's choice of judge matters enormously, because that judge will run the entire litigation, sometimes for years, and different judges manage these cases differently. The JPML's role and the dockets it oversees are public through the Panel itself. Once the Panel issues its transfer order, the existing cases get shipped to that judge, and new cases filed anywhere in the federal system that fit the litigation get funneled there too.
This is why you'll see a mass tort described with a specific court and judge: "MDL 2738, in the District of New Jersey, before Judge Shipp," for the talc cases, or the firefighting-foam litigation before a particular judge in South Carolina. That's the transferee court the Panel assigned, the single place all those federal cases now live for their pretrial life.
What happens inside an MDL
Once consolidated, the litigation goes through the heavy lifting that's common to all the cases, and this is where most of the real work and the real drama happen.
Discovery gets done once, collectively. Instead of each plaintiff separately demanding the company's internal documents, the cases pool their efforts: the corporate records, the internal emails, the studies, the depositions of company executives, all of it gets handled centrally for the whole group. This is often where the consequential evidence surfaces, what the company knew and when.
The science gets litigated, once. In toxic-exposure and drug cases especially, there's usually a pivotal fight over general causation, whether the product is even capable of causing the claimed harm, fought through expert testimony and gatekeeping rulings by the judge. We've seen this be the decisive gate in cases like the Depo-Provera litigation and the hair-relaxer cases, where whether the plaintiffs' science clears the bar determines whether the entire MDL moves forward or collapses. Doing that fight once, for all the cases, is exactly the efficiency an MDL is built for.
Big common motions get decided once. Whether the claims are legally viable, whether a defense like federal preemption knocks them out, these get ruled on for the whole group rather than relitigated case by case.
Bellwether trials: the MDL's signature move
The feature that most distinguishes how MDLs resolve is the bellwether trial, and it's worth understanding because it's how these cases find their value.
After the common discovery and science are done, the court selects a small number of representative cases, often a handful chosen to reflect the range of the litigation, and tries them first. These bellwether trials are real trials with real juries and real verdicts. But here's the key: a bellwether verdict doesn't bind the other thousands of cases. Your neighbor's loss in a bellwether doesn't decide your case.
What bellwethers do is reveal value. When both sides watch a few representative cases go before juries and see what those juries do, award millions, award nothing, split the difference, the guesswork drains out of the situation. Both sides get a read on what the cases are actually worth in front of real jurors, and that read is usually what finally drives a global settlement. This is why, across nearly every mass tort, the looming bellwether trials are the event everyone watches: they're the price-discovery mechanism for the whole litigation. We dig into how that translates into actual money in how mass tort settlements pay out.
After the MDL: remand and resolution
In theory, once the common pretrial work is finished, cases that don't settle can be sent back, "remanded," to the federal courts where they were originally filed, to be tried individually. The MDL handles the shared pretrial phase; the individual trials, if they happen, go home.
In practice, most MDL cases never get remanded for individual trials, because the litigation resolves first. The bellwether results push the parties toward a global settlement that covers the bulk of the cases, and the MDL winds down through that settlement rather than thousands of separate trials. But the remand mechanism is the structural backstop, and the possibility of cases going back out for individual trials is part of what gives plaintiffs leverage in settlement talks.
The crucial thing an MDL is not: a class action
Here's the misconception to kill, because it's the most common one. An MDL is not a class action. They're genuinely different things, and the difference matters for anyone with a case.
In a class action, there's one lawsuit, a representative plaintiff sues on behalf of everyone in the class, and a single outcome binds all class members at once. In an MDL, every plaintiff keeps their own separate lawsuit. You have your own case, your own lawyer, your own individual claim and your own individual damages. The cases are consolidated for the efficient handling of common questions, but they were never merged into one case, and no single judgment automatically binds everyone. After the common work is done, the individualized parts, your specific injury, your specific damages, remain yours.
This is why MDLs are the vehicle for personal-injury mass torts where everyone's situation is different, one person has kidney cancer, another testicular cancer, another a different injury entirely, with different exposures and different damages. Those differences are too individual for a class action, which needs the claims to be largely uniform. The MDL gives you the efficiency of pooled common work while preserving your individual case. We lay out that distinction fully in mass tort vs class action, because confusing the two leads people to badly wrong assumptions about what they're owed and whether they're bound by something they never agreed to.
Why this matters to you
If you have a potential claim in one of these litigations, understanding the MDL structure changes how you read the news and how you understand your own position.
It tells you that "the AFFF MDL hasn't settled" doesn't mean your individual claim was rejected, it means the common, collective phase is still working through its science and its bellwethers. It tells you that a bellwether verdict you read about, a big win or a defense victory, doesn't directly decide your case, it's a data point that moves the whole negotiation. It tells you that your case retains its individual identity even though it's pooled with thousands of others, so your specific facts still matter. And it tells you that the timeline is long, because the common work, discovery, science, motions, bellwethers, takes years before resolution, which is simply how these cases are built.
The three letters stop being mysterious once you see the machine. An MDL is thousands of individual lawsuits, gathered before one judge, to do the shared work once, find the cases' value through test trials, and then resolve, usually through a global settlement, while each plaintiff keeps their own claim the whole way through. Nearly every mass tort you'll read about runs on exactly this structure. Knowing it is the key that unlocks all the rest.